Who Paid My Doc
Acp-103-033
ClinicalTrials.gov NCT03118947
Research payments
$112,134
Through program year 2019, $112,134 in research payments was reported against Acp-103-033, across 65 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03118947
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $112,134 | 65 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ashok Patel Toms River, NJ Named on 13 payments
- Perminder Bhatia Fresno, CA Named on 8 payments
- Kiran Bath Fullerton, CA Named on 8 payments
- Gustavo Alva Costa Mesa, CA Named on 6 payments
- Raymond Turner Washington, DC Named on 5 payments
- David Weisman Willow Grove, PA Named on 4 payments
- Clifford Singer Bangor, ME Named on 4 payments
- Marc Agronin Miami, FL Named on 3 payments
- William Justiz Naples, FL Named on 2 payments
- Mohammad Bolouri Charlotte, NC Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.